Correction to: Resveratrol Mitigates Cerebral Ischemic Injury by Altering Levels of Trace Elements, Toxic Metal, Lipid Peroxidation, and Antioxidant Activity

Correction to: Biological Trace Element Research

https://doi.org/10.1007/s12011-020-02497-x

The published version of this article unfortunately contained mistakes.

In the Results section under the header Lipid Peroxidation Levels in the Brain Cortex, the paragraph "MDA is the end-product of lipid peroxidation and is commonly used to assess oxidative stress. The MDA level in the control, ligation, resveratrol, and prevention groups is 13.85 ± 0.38, 15.70 ± 0.42, 10.75 ± 1.21, and 13.48 ± 0.47 μmol/g protein, respectively (Fig. 1). The MDA level in the prevention group was significantly lower than that of the ligation group (P < 0.01)." should be chnaged to "MDA is the end-product of lipid peroxidation and is commonly used to assess oxidative stress. The MDA level in the control, ligation, resveratrol, and prevention groups is 16.75 ± 0.31, 18.99 ± 0.44, 13.01 ± 1.12, and 16.31 ± 0.43 μmol/g protein, respectively (Fig. 1). The MDA level in the prevention group was significantly lower than that of the ligation group (P < 0.01)."

Still in the Results section under the header Antioxidant Activity in Brain Cortex Homogenates, the first two sentences which reads "The SOD activity in the control, ligation, resveratrol, and pre-vention group was 0.94 ± 0.02, 0.62 ± 0.04, 1.12 ± 0.02, and 1.23 ± 0.02 U/mg protein, respectively. SOD activity is significantly higher in the prevention group than in the ligation group (P < 0.01) (Fig. 6). Catalase (CAT) activity in the control, ligation, resveratrol, and prevention group was 8.71 ± 0.31, 5.59 ± 0.24, 10.18 ± 0.43, and 7.10 ± 0.24 μmol/mg protein, respectively. As listed in Fig. 7, the CAT activity is significantly higher in the prevention group than in the ligation group (P < 0.01)." should be changed to "The SOD activity in the control, ligation, resveratrol, and prevention group was 1.13 ± 0.02, 0.75 ± 0.06, 1.35 ± 0.01, and 1.47 ± 0.02 U/mg protein, respectively. SOD activity is significantly higher in the prevention group than in the ligation group (P < 0.01) (Fig. 6). Catalase (CAT) activity in the control, ligation, resveratrol, and prevention group was 10.53 ± 0.24, 6.77 ± 0.44, 12.32 ± 0.37, and 8.57 ± 0.33 μmol/ mg protein, respectively. As listed in Fig. 7, the CAT activity is significantly higher in the prevention group than in the ligation group (P < 0.01)."

Fig. 1 was changed from

Fig. 1 Malondialdehyde (MDA) level in brain cortex homogenates. Data are expressed as the mean ± SD and were analyzed using the Kruskal-Wallis oneway analysis of variance (ANOVA) followed by Fisher’s least significant difference test. Statistical differences were considered significant at P < 0.05. a P < 0.05 vs. control group. b P < 0.05 vs. ligation group

to

Fig. 1 Malondialdehyde (MDA) level in brain cortex homogenates. Data are expressed as the mean ± SD and were analyzed using the Kruskal-Wallis oneway analysis of variance (ANOVA) followed by Fisher’s least significant difference test. Statistical differences were considered significant at P < 0.05. a P < 0.05 vs. control group. b P < 0.05 vs. ligation group

Fig. 6 was changed from

Fig. 6 Superoxide dismutase (SOD) activity in brain cortex homogenates. Data are expressed as the mean ± SD and were analyzed using the Kruskal-Wallis ANOVA followed by Fisher’s least significant difference test. Statistical differences were considered significant at P < 0.05. a P < 0.05 vs. control group. b P < 0.05 vs. ligation subject

to

Fig. 6 Superoxide dismutase (SOD) activity in brain cortex homogenates. Data are expressed as the mean ± SD and were analyzed using the Kruskal-Wallis ANOVA followed by Fisher’s least significant difference test. Statistical differences were considered significant at P < 0.05. a P < 0.05 vs. control group. b P < 0.05 vs. ligation subject

Fig. 7 was changed from

Fig. 7 Catalase (CAT) activity in brain cortex homogenates. Data are expressed as the mean ± SD and were analyzed using the Kruskal-Wallis ANOVA followed by Fisher’s least significant difference test. Statistical differences were considered significant at P <0.05. a P <0.05 vs. control group. b P< 0.05 vs. ligation subject

to

Fig. 7 Catalase (CAT) activity in brain cortex homogenates. Data are expressed as the mean ± SD and were analyzed using the Kruskal-Wallis ANOVA followed by Fisher’s least significant difference test. Statistical differences were considered significant at P <0.05. a P <0.05 vs. control group. b P< 0.05 vs. ligation subject

The original article has been corrected.